Friday, May 24, 2013 Last update: 2:05 PM
Company Tech News as it Breaks
Trade Events
Zalicus Inc.
News articles for Zalicus Inc.:
Friday, May 10, 2013
- Zalicus Presents Data on Novel, Oral, N- and T-Type Calcium Channel Blockers for the Treatment of PainZalicus Inc. (Nasdaq Capital Market: ZLCS) today announced that preclinical data highlighting its novel, oral ion channel programs for the treatment of ... read more
Wednesday, May 8, 2013
- Zalicus Secures New $25 Million Funding Commitment from Lincoln Park CapitalZalicus Inc. (Nasdaq Capital Market: ZLCS), a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain, today announced ... read more
Thursday, May 2, 2013
- Zalicus Reports Financial Results for the First Quarter 2013Zalicus Inc. (Nasdaq Capital Market: ZLCS), a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain, today reported ... read more
Tuesday, April 2, 2013
- Zalicus Granted Key Formulation Patent for Z160Zalicus Inc. (Nasdaq Global Market: ZLCS), a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain, today announced ... read more
Tuesday, March 19, 2013
- Zalicus Presents Data Demonstrating Advantages of State-Dependent Ion Channel ScreeningZalicus Inc. (Nasdaq Global Market: ZLCS) today announced that preclinical data showing the advantages of applying Zalicus’s state dependent screening approach to ... read more
Wednesday, March 6, 2013
- Zalicus Reports Financial Results for the Fourth Quarter and Year End 2012Zalicus Inc. (Nasdaq Global Market: ZLCS), a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain, today reported ... read more
Wednesday, February 20, 2013
- Zalicus Granted Composition-of-Matter Patent for Z944Zalicus Inc. (Nasdaq Global Market: ZLCS), a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain, today announced ... read more
Tuesday, February 5, 2013
- Zalicus to Present at the 2013 BIO CEO & Investor ConferenceZalicus Inc. (NASDAQ: ZLCS), a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain, today announced that Zalicus ... read more
Thursday, January 3, 2013
- Zalicus Initiates the Second of Two Phase 2a Studies with Z160Zalicus Inc. (NASDAQ: ZLCS), a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain, today announced that it has initiated the second of two ... read more
Wednesday, December 5, 2012
- Zalicus to Present at the Oppenheimer 23rd Annual Healthcare ConferenceZalicus Inc. (NASDAQ: ZLCS), a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain, today announced that Zalicus ... read more